As chemo/radiotherapy was of great importance to patient prognosis, a stratified analysis of the effect of prechemotherapy/radiotherapy on OS was conducted, and the results showed that the prognostic value of ezrin expression in patients with bone and soft tissue sarcomas was not altered. The gene discussed is EZR; the disease is soft tissue sarcoma.